Free Trial

Mizuho Securities USA LLC Trims Position in CVS Health Corporation (NYSE:CVS)

CVS Health logo with Medical background

Key Points

  • Mizuho Securities USA LLC has reduced its holdings in CVS Health Corporation by 15.4%, now owning a total of 100,952 shares valued at approximately $6.84 million.
  • CVS Health Corporation reported an earnings per share (EPS) of $1.81, surpassing estimates, along with a revenue of $98.92 billion for the most recent quarter, marking an 8.4% increase year-over-year.
  • The company announced a quarterly dividend of $0.665 per share, representing a 4.1% dividend yield and a payout ratio of 74.30%.
  • Want stock alerts on CVS Health? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Mizuho Securities USA LLC decreased its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 15.4% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 100,952 shares of the pharmacy operator's stock after selling 18,317 shares during the period. Mizuho Securities USA LLC's holdings in CVS Health were worth $6,839,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CVS. McIlrath & Eck LLC lifted its position in CVS Health by 32.6% during the fourth quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the period. Costello Asset Management INC lifted its position in CVS Health by 281.3% during the first quarter. Costello Asset Management INC now owns 572 shares of the pharmacy operator's stock valued at $39,000 after purchasing an additional 422 shares during the period. Park Square Financial Group LLC purchased a new stake in CVS Health during the fourth quarter valued at approximately $43,000. GW&K Investment Management LLC increased its holdings in CVS Health by 39.4% during the first quarter. GW&K Investment Management LLC now owns 637 shares of the pharmacy operator's stock valued at $43,000 after buying an additional 180 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL increased its holdings in CVS Health by 77.2% during the fourth quarter. Strategic Investment Solutions Inc. IL now owns 1,024 shares of the pharmacy operator's stock valued at $46,000 after buying an additional 446 shares during the last quarter. Institutional investors own 80.66% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have commented on CVS shares. Barclays upped their target price on shares of CVS Health from $79.00 to $80.00 and gave the company an "overweight" rating in a report on Friday, August 1st. Wall Street Zen raised shares of CVS Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. Truist Financial upped their target price on shares of CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a report on Monday, May 12th. UBS Group reduced their target price on shares of CVS Health from $71.00 to $67.00 and set a "neutral" rating for the company in a report on Tuesday, July 22nd. Finally, Bernstein Bank reduced their price objective on shares of CVS Health from $78.00 to $72.00 and set a "market perform" rating for the company in a research note on Wednesday, July 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $75.11.

Check Out Our Latest Stock Report on CVS Health

CVS Health Price Performance

CVS stock traded down $0.64 during trading on Monday, hitting $64.91. 5,554,636 shares of the company's stock traded hands, compared to its average volume of 9,220,690. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The business has a fifty day simple moving average of $64.71 and a 200 day simple moving average of $64.45. The stock has a market capitalization of $82.32 billion, a price-to-earnings ratio of 18.13, a P/E/G ratio of 0.72 and a beta of 0.58.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 EPS for the quarter, beating the consensus estimate of $1.46 by $0.35. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. The business had revenue of $98.92 billion during the quarter, compared to analyst estimates of $94.87 billion. During the same quarter last year, the business earned $1.83 earnings per share. CVS Health's quarterly revenue was up 8.4% compared to the same quarter last year. As a group, research analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, August 1st. Stockholders of record on Tuesday, July 22nd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.1%. The ex-dividend date was Tuesday, July 22nd. CVS Health's dividend payout ratio (DPR) is 74.30%.

Insider Activity

In other news, Director Guy P. Sansone bought 1,570 shares of the stock in a transaction dated Thursday, June 5th. The stock was purchased at an average price of $63.70 per share, for a total transaction of $100,009.00. Following the acquisition, the director owned 12,007 shares of the company's stock, valued at $764,845.90. The trade was a 15.04% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 1.22% of the company's stock.

About CVS Health

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Growth Stock Winners to Watch And 3 to Avoid
3 Growth Stocks That Could Pop Before Summer Ends
3 Buy-the-Dip Stocks Poised to Rebound Soon

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines